These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12454822)

  • 41. Diverse B-cell tumors associated with t(14;19)(q32;q13)/IGH::BCL3 identified by G-banding and fluorescence in situ hybridization.
    Ohno H; Maekawa F; Hayashida M; Nakagawa M; Fukutsuka K; Matsumura M; Takeoka K; Maruyama W; Ukyo N; Sumiyoshi S; Tanaka Y; Haga H
    J Clin Exp Hematop; 2024; 64(1):21-31. PubMed ID: 38538317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paraimmunoblastic variant of small lymphocytic lymphoma/leukemia.
    Pugh WC; Manning JT; Butler JJ
    Am J Surg Pathol; 1988 Dec; 12(12):907-17. PubMed ID: 3059831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
    Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
    Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biallelic IgH rearrangements in patients with indolent lymphoproliferative disorders: molecular and practical implications.
    Cerny J; Slavickova A; Krepelova A; Trneny M; Karban J; Klener P
    J Cell Physiol; 2004 May; 199(2):217-26. PubMed ID: 15040004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined molecular biological and molecular cytogenetic analysis of genomic changes in 146 patients with B-cell chronic lymphocytic leukemia.
    Berkova A; Pavlistova L; Babicka L; Houskova L; Tajtlova J; Balazi P; Cmunt E; Schwarz J; Karban J; Trneny M; Brezinova J; Zemanova Z; Michalova K
    Neoplasma; 2008; 55(5):400-8. PubMed ID: 18665750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiple lymphomatous polyposis associated with small lymphocytic lymphoma: a unique presentation.
    Khaled S; Gotlieb V; Schuster IP; Saif MW
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):461-3. PubMed ID: 19104711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
    Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
    Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia.
    Patel A; Kang SH; Lennon PA; Li YF; Rao PN; Abruzzo L; Shaw C; Chinault AC; Cheung SW
    Am J Hematol; 2008 Jul; 83(7):540-6. PubMed ID: 18161787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conventional cytogenetics in chronic lymphocytic leukemia (CLL).
    Krings Rocha C; Wendtner CM; Hallek M; Kreuzer KA
    Leuk Res; 2011 Mar; 35(3):e25. PubMed ID: 21074268
    [No Abstract]   [Full Text] [Related]  

  • 52. V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia.
    Duke VM; Gandini D; Sherrington PD; Lin K; Heelan B; Amlot P; Mehta AB; Hoffbrand AV; Foroni L
    Haematologica; 2003 Nov; 88(11):1259-71. PubMed ID: 14607755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.
    Belaud-Rotureau MA; Parrens M; Carrere N; Turmo M; Ferrer J; de Mascarel A; Dubus P; Merlio JP
    Hum Pathol; 2007 Feb; 38(2):365-72. PubMed ID: 17134735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cryopreserved chronic lymphocytic leukemia cells analyzed by multicolor fluorescence in situ hybridization after optimized mitogen stimulation.
    Karhu R; Vilpo L; Isola J; Knuutila S; Vilpo J
    Genes Chromosomes Cancer; 2002 Jul; 34(3):345-8. PubMed ID: 12007196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
    He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
    Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV.
    Valgañón M; Giraldo P; Agirre X; Larráyoz MJ; Rubio-Martinez A; Rubio-Felix D; Calasanz MJ; Odero MD
    Br J Haematol; 2005 Apr; 129(1):53-9. PubMed ID: 15801955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Squamous cell carcinoma of the uterine cervix in association with stage 0 chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Mikami Y; Maehata K; Fujiwara K; Sasano H
    Gynecol Oncol; 2004 Mar; 92(3):974-7. PubMed ID: 14984969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integration of conventional cytogenetics, comparative genomic hybridisation and interphase fluorescence in situ hybridisation for the detection of genomic rearrangements in acute leukaemia.
    McGrattan P; Campbell S; Cuthbert R; Jones FG; McMullin MF; Humphreys M
    J Clin Pathol; 2008 Aug; 61(8):903-8. PubMed ID: 18474541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: a prospective analysis.
    Brejcha M; Stoklasová M; Brychtová Y; Panovská A; Štěpanovská K; Vaňková G; Plevová K; Oltová A; Horká K; Pospíšilová Š; Mayer J; Doubek M
    Leuk Res; 2014 Feb; 38(2):170-5. PubMed ID: 24246692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The 9p24.3 breakpoint of a constitutional t(6;9)(p12;p24) in a patient with chronic lymphocytic leukemia maps close to the putative promoter region of the DMRT2 gene.
    Rüssel J; Dutta U; Wand D; Schlote D; Hansmann I
    Cytogenet Genome Res; 2009; 125(2):81-6. PubMed ID: 19729909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.